Pranjali Pranjali, Meher Mukesh Kumar, Raj Ritu, Prasad Narayan, Poluri Krishna Mohan, Kumar Dinesh, Guleria Anupam
Centre of Biomedical Research, SGPGIMS Campus, Lucknow 226014, India.
Department of Biotechnology and Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, India.
ACS Omega. 2019 Nov 6;4(21):19255-19264. doi: 10.1021/acsomega.9b02615. eCollection 2019 Nov 19.
Owing to the peculiar broad-spectrum antimicrobial activities of zinc oxide nanoparticles (ZnO NPs), we envisaged their use to treat bacterial/mycobacterial/fungal infections during peritoneal dialysis (PD) of end-stage renal failure patients. However, a recent study from our lab showed that ZnO-NPs cannot be employed for the same in their naked form owing to their rapid agglomeration. Also, the naked ZnO-NPs showed strong interaction with organic acids present in the PD fluid (i.e., lactate and citrate present abundantly in almost all biological fluids) resulting in the formation of bioconjugates. Here, we propose that the surface coating of ZnO NPs may inhibit the binding interactions of NPs with the constituents of PD fluid. Therefore, in this study, we have carried out the surface coating of ZnO NPs with polyethylene glycol (PEG) of different molecular weights, followed by the investigations of physicochemical properties of PEGylated ZnO NPs dispersed in PD fluid using nuclear magnetic resonance (NMR) spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM), and Fourier transform infrared (FT-IR) spectroscopy. The interaction of PEGylated ZnO NPs has also been studied separately in glucose and lactic acid which are the main constituents of PD fluid and in citric acid. Although the X-ray diffraction and TEM results infer the colloidal stability of PEGylated ZnO NPs in PD fluid, FT-IR, UV-vis, and nuclear magnetic resonance results revealed the binding interactions of PEGylated ZnO NPs with the PD constituents. PEGylated ZnO NPs also interact strongly with the lactic acid and citric acid, leading to agglomeration, as observed previously for uncoated ZnO NPs. Further, the antibacterial activities of bare and PEG-coated ZnO NPs dispersion in PD fluid have been studied. A reduction in the bacterial inhibition effect against and was observed for both the bare and PEG-coated ZnO NPs dispersed in PD fluid, indicating that the complex nature of PD fluid counteract on the efficiency of these nanobiotics.
由于氧化锌纳米颗粒(ZnO NPs)具有独特的广谱抗菌活性,我们设想将其用于治疗终末期肾衰竭患者腹膜透析(PD)期间的细菌/分枝杆菌/真菌感染。然而,我们实验室最近的一项研究表明,由于ZnO-NPs会迅速团聚,因此不能以其裸态形式用于上述治疗。此外,裸态ZnO-NPs与腹膜透析液中存在的有机酸(即几乎所有生物流体中大量存在的乳酸和柠檬酸)表现出强烈的相互作用,导致形成生物共轭物。在此,我们提出ZnO NPs的表面涂层可能会抑制NPs与腹膜透析液成分的结合相互作用。因此,在本研究中,我们用不同分子量的聚乙二醇(PEG)对ZnO NPs进行了表面涂层,随后使用核磁共振(NMR)光谱、动态光散射(DLS)、透射电子显微镜(TEM)和傅里叶变换红外(FT-IR)光谱研究了分散在腹膜透析液中的聚乙二醇化ZnO NPs的物理化学性质。还分别在腹膜透析液的主要成分葡萄糖和乳酸以及柠檬酸中研究了聚乙二醇化ZnO NPs的相互作用。尽管X射线衍射和TEM结果推断聚乙二醇化ZnO NPs在腹膜透析液中的胶体稳定性,但FT-IR、紫外可见光谱和核磁共振结果揭示了聚乙二醇化ZnO NPs与腹膜透析液成分的结合相互作用。聚乙二醇化ZnO NPs也与乳酸和柠檬酸强烈相互作用,导致团聚,这与之前观察到的未涂层ZnO NPs的情况相同。此外,还研究了裸露的和聚乙二醇涂层的ZnO NPs分散在腹膜透析液中的抗菌活性。观察到分散在腹膜透析液中的裸露的和聚乙二醇涂层的ZnO NPs对 和 的细菌抑制作用均有所降低,这表明腹膜透析液的复杂性质会抵消这些纳米抗生素的效率。